Navigation Links
Sirion Therapeutics Preclinical Studies: Two New Potential Advances in Treatment of Retinal Diseases to be Presented at ARVO
Date:4/21/2008

TAMPA, Fla., April 21 /PRNewswire/ -- Sirion Therapeutics, Inc., a privately held ophthalmic-focused biopharmaceutical company, announced today that preclinical results for two new compounds targeted for the treatment of retinal diseases will be presented during the 2008 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO), April 27 - May 1, Ft. Lauderdale, FL.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080220/CLW064LOGO )

"We are very excited by the potential application of the basic research being conducted by our drug discovery team," said Barry Butler, President and CEO of Sirion Therapeutics, Inc. "Sirion's targeted research approach enables us to rapidly identify new compounds and test their viability in disease models. The two classes of compounds presented at ARVO could have utility in a number of ophthalmic disease states, including macular degeneration, Stargardt's disease and diabetic eye disease."

Sirion's two-fold corporate strategy consists of 1) completing the development and commercialization of late-stage product candidates focused on the front of the eye and 2) development of innovative treatments for back of the eye diseases. The company's new drug application for Durezol(TM) (difluprednate ophthalmic emulsion) 0.05%, a topical steroid for the treatment of postoperative ocular inflammation, has been accepted for filing and granted priority review by the US Food and Drug Administration. Sirion's strong preclinical research program is centered at its dedicated drug discovery facility in San Diego, CA.

[Note: Durezol(TM) is the trademark of Sirion Therapeutics, Inc. and is currently under review by the U.S. Food and Drug Administration and has not yet been cleared as the trade name for commercial use.]

New Class of Oxidative Stress Modulator

"Development of Topically Applied Modulators of
'/>"/>

SOURCE Sirion Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Sirion Therapeutics Highlights Pivotal Trial Results of Durezol(TM) at the American Society of Cataract and Refractive Surgery Annual Symposium
2. Sirion Therapeutics Acquires Worldwide License to Develop New Treatment for Ocular Diseases
3. Sirion Therapeutics Supports Ophthalmic Education
4. CardioVascular BioTherapeutics, Inc. Announces Update on Timing of Form 10-K Filing
5. Cell Therapeutics, Inc. Announces Receipt of Letter From the NASDAQ Stock Market Regarding Non-Compliance With the Minimum Bid Price Requirement
6. BioSpace and IBC Life Sciences Announce Career Fair Alliance For Drug Discovery & Development of Innovative Therapeutics World Congress
7. Lorus Therapeutics presents new findings for the anticancer drugs LOR-253 and LOR-2040
8. CV Therapeutics Announces $185 Million Transaction with TPG-Axon Capital for Half of Royalty for Lexiscan(TM) (regadenoson) Injection
9. ImaRx Therapeutics Receives Notification from NASDAQ Regarding Non-Compliance with NASDAQs Minimum Bid Price Requirement
10. CV Therapeutics and Astellas Announce FDA Approval for Lexiscan(TM) (regadenoson) Injection
11. Stemline Therapeutics Raises $12.5 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 /PRNewswire/ - iCo Therapeutics ... today reported financial results for the six months ... are expressed in Canadian dollars and presented under ... Quarter 2014 Highlights , Announced top-line ... (VA) primary endpoint for subjects enrolled in the ...
(Date:8/29/2014)... Due to a misstatement posted by the ... Cell Technology Center, LLC ( ASCTC ) was reported as ... that might benefit ALS patients. Because of ASCTC's exclusive ... technologies and therapeutic applications, FRC listed ASCTC as one of ... who wish not to support research that requires the death ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 SPIE Fellow ... Physics and Optical Science and Director of the Center ... North Carolina at Charlotte, and co-founder and Chairman of ... serve as the 2015 Vice President of SPIE, the ... President Philip Stahl announced recent election results at the ...
(Date:8/28/2014)... “This kit has an improved extraction efficiency and provides users ... said Mark Tess, PhD, Mycotoxin Product Manager for Charm Sciences. ... USDA-GIPSA inspection agencies that have a need to detect aflatoxin ... a matter of minutes with nothing but our equipment and ... grain before accepting it, but they no longer have to ...
Breaking Biology Technology:iCo Therapeutics Announces Second Quarter 2014 Financial Results 2iCo Therapeutics Announces Second Quarter 2014 Financial Results 3iCo Therapeutics Announces Second Quarter 2014 Financial Results 4The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 2The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 3Glenn Boreman, UNC Professor and Plasmonics Co-Founder, Elected to SPIE Presidential Chain 2
... SAN DIEGO, Jan. 13 NexBio, a privately held ... that David Wurtman, MD, MBA, Vice President of Corporate ... 2009 Biotech Showcase in San Francisco, CA, on January ... to save lives and to improve the quality of ...
... BOSTON, Jan. 13 Johnston Blakely & Company, ... to announce that Michael,D. Webb has joined the ... Mr. Webb will,participate with the firm on internal ... and private equity placements, with a,particular focus on ...
... HOPE, Pa., Jan. 13 Jubilant Organosys,Ltd., ... today that its,Bangalore-based subsidiary, Jubilant Biosys Ltd., ... BioLeap, LLC, USA. Under this partnership, ... computational fragment,based drug design platform with Jubilant,s ...
Cached Biology Technology:NexBio to Present at 2009 Biotech Showcase 2NexBio to Present at 2009 Biotech Showcase 3Jubilant and BioLeap Announce New Partnership in Drug Discovery 2Jubilant and BioLeap Announce New Partnership in Drug Discovery 3
(Date:8/29/2014)... Kansas City, MO. - In a cell,s nucleus, ... known as histones, an amalgam biologists call chromatin. ... as a nuclear "sidekick," the mere packing material ... Recently, however, biologists have developed a greater appreciation ... In 2012, investigators from multiple research institutions studying ...
(Date:8/28/2014)... America (ESA) is pleased to announce the selection of ... Society. Honorary Membership acknowledges those who have served ESA ... the affairs of the Society that has reached an ... the ESA Governing Board and then voted on by ... the Awards Ceremony at Entomology 2014, ESA,s Annual Meeting ...
(Date:8/28/2014)... traditional cigarettes, but still release toxins into the ... , Scientists studying secondhand smoke from e-cigarettes discovered ... particles, with close-to-zero exposure to organic carcinogens. However, ... second-hand e-cigarette smoke were found to be significantly ... of polycyclic aromatic hydrocarbons cancer-causing organic compounds ...
Breaking Biology News(10 mins):'K-to-M' histone mutations: How repressing the repressors may drive tissue-specific cancers 2'K-to-M' histone mutations: How repressing the repressors may drive tissue-specific cancers 3Fred Baxendale selected as Honorary Member of the Entomological Society of America 2Second-hand e-cig smoke compared to regular cigarette smoke 2
... A team of researchers, led by biologists at Dartmouth, ... in Lake Baiyangdian, the largest lake in the North ... drinking water for the people who live around it. ... Lake Baiyangdian, all at varying distances from major sources ...
... Is getting new knees on your list of New ... indicates that women wait longer to pursue knee-replacement surgery ... can no longer stand the pain, these women may ... on hold indefinitely, according to Lynn Snyder-Mackler, Distinguished Alumni ...
... If youre worried about high cholesterol levels and keeping ... and eggs just yet. A new study says they ... University have discovered that lower cholesterol levels can actually ... assistant professor of health and kinesiology, and Simon Sheather, ...
Cached Biology News:Dartmouth researchers alarmed by levels of mercury and arsenic in Chinese freshwater ecosystem 2Listen-up ladies: Don't postpone knee-replacement surgery 2Listen-up ladies: Don't postpone knee-replacement surgery 3Surprise -- cholesterol may actually pose benefits, study shows 2
Natural Mouse Laminin is purified from the Engelbreth-Holm-Swarm (EHS) sarcoma and is provided in Tris-buffered saline....
EPH electrode, cathode, 1. Category: Electrophoresis Systems & Standards & Reagents, IEF & SDS-PAGE & 2-D Electrophoresis, Multiphor II Kits & Components and Accessories....
... paraffin tissue array is designed for ... interest in extensive panels of different ... heart, kidney, liver, lung, muscle, spleen ... positively charged glass slide. Each ...
Rat Normal Multiple Tissue Array 1 slide...
Biology Products: